Literature DB >> 1901701

Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase.

S Milewski1, R Andruszkiewicz, L Kasprzak, J Mazerski, F Mignini, E Borowski.   

Abstract

The mechanism of anticandidal action of novel synthetic dipeptides containing N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP) residues was shown to be consistent with the "warhead delivery" concept. FMDP dipeptides were shown to be transported into Candida albicans cells by the di-tripeptide permease and subsequently hydrolyzed by intracellular peptidases, especially aminopeptidase. The anticandidal activity of the particular FMDP dipeptide was influenced by the rate of its transport and, to a lower extent, by the intracellular cleavage rate. A high transport rate accompanied by a high cleavage rate resulted in the high anticandidal activity of L-norvalyl-FMDP. The strong growth-inhibitory effect of this compound was the consequence of inhibition of the enzyme glucosamine-6-phosphate synthase by the released FMDP. The action of L-norvalyl-FMDP on exponentially growing C. albicans cells resulted in a sharp decrease of incorporation of 14C label from [14C]glucose into chitin, mannoprotein, and glucan. This effect, as well as the growth-inhibitory effect, was fully reversed by exogenous N-acetyl-D-glucosamine. Glucosamine-6-phosphate synthase was proved to be the only essential target for FMDP dipeptides. Scanning electron microscopy of C. albicans cells treated with L-norvalyl-FMDP revealed highly distorted, wrinkled, and collapsed forms. Cells formed long, bulbous chains, and partial lysis occurred.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901701      PMCID: PMC244938          DOI: 10.1128/AAC.35.1.36

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT2 by fumaroyl diaminopropanoic acid derivatives, a novel group of glutamine analogs.

Authors:  H Chmara; R Andruszkiewicz; E Borowski
Journal:  Biochim Biophys Acta       Date:  1986-03-28

2.  Synthesis of N3-fumaramoyl-L-2,3-diaminopropanoic acid analogues, the irreversible inhibitors of glucosamine synthetase.

Authors:  R Andruszkiewicz; H Chmara; S Milewski; E Borowski
Journal:  Int J Pept Protein Res       Date:  1986-05

3.  Susceptibility of yeast-like fungi to a new antifungal agent, LY 121019.

Authors:  A N Bulo; S F Bradley; C A Kauffman
Journal:  Mycoses       Date:  1988-06       Impact factor: 4.377

4.  Synthetic derivatives of N3-fumaroyl-L-2,3-diaminopropanoic acid inactivate glucosamine synthetase from Candida albicans.

Authors:  S Milewski; H Chmara; R Andruszkiewicz; E Borowski
Journal:  Biochim Biophys Acta       Date:  1985-04-29

5.  Synthesis and biological properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid dipeptides, a novel group of antimicrobial agents.

Authors:  R Andruszkiewicz; H Chmara; S Milewski; E Borowski
Journal:  J Med Chem       Date:  1987-10       Impact factor: 7.446

6.  A novel peptide delivery system involving peptidase activated prodrugs as antimicrobial agents. Synthesis and biological activity of peptidyl derivatives of 5-fluorouracil.

Authors:  W D Kingsbury; J C Boehm; R J Mehta; S F Grappel; C Gilvarg
Journal:  J Med Chem       Date:  1984-11       Impact factor: 7.446

7.  The mode of action of bacilysin and anticapsin and biochemical properties of bacilysin-resistant mutants.

Authors:  M Kenig; E Vandamme; E P Abraham
Journal:  J Gen Microbiol       Date:  1976-05

8.  Purification and properties of three intracellular proteinases from Candida albicans.

Authors:  F Portillo; C Gancedo
Journal:  Biochim Biophys Acta       Date:  1986-04-11

9.  Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase.

Authors:  S Milewski; H Chmara; R Andruszkiewicz; E Borowski; M Zaremba; J Borowski
Journal:  Drugs Exp Clin Res       Date:  1988

10.  Illicit transport: the oligopeptide permease.

Authors:  B N Ames; G F Ames; J D Young; D Tsuchiya; J Lecocq
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

View more
  9 in total

1.  Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals.

Authors:  S Milewski; F Mignini; R Prasad; E Borowski
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  The nonribosomal peptide synthetase enzyme DdaD tethers N(β)-fumaramoyl-l-2,3-diaminopropionate for Fe(II)/α-ketoglutarate-dependent epoxidation by DdaC during dapdiamide antibiotic biosynthesis.

Authors:  Marie A Hollenhorst; Stefanie B Bumpus; Megan L Matthews; J Martin Bollinger; Neil L Kelleher; Christopher T Walsh
Journal:  J Am Chem Soc       Date:  2010-11-10       Impact factor: 15.419

3.  A head-to-head comparison of eneamide and epoxyamide inhibitors of glucosamine-6-phosphate synthase from the dapdiamide biosynthetic pathway.

Authors:  Marie A Hollenhorst; Ioanna Ntai; Bernard Badet; Neil L Kelleher; Christopher T Walsh
Journal:  Biochemistry       Date:  2011-04-26       Impact factor: 3.162

4.  Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans.

Authors:  Fernanda L Fonseca; Leonardo Nimrichter; Radames J B Cordero; Susana Frases; Jessica Rodrigues; David L Goldman; Ryszard Andruszkiewicz; Slawomir Milewski; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2009-07-17

5.  Enhanced susceptibility to antifungal oligopeptides in yeast strains overexpressing ABC multidrug efflux pumps.

Authors:  Roland Wakiec; Iwona Gabriel; Rajendra Prasad; Jeffrey M Becker; John W Payne; Slawomir Milewski
Journal:  Antimicrob Agents Chemother       Date:  2008-09-15       Impact factor: 5.191

6.  The ATP-dependent amide ligases DdaG and DdaF assemble the fumaramoyl-dipeptide scaffold of the dapdiamide antibiotics.

Authors:  Marie A Hollenhorst; Jon Clardy; Christopher T Walsh
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

7.  Fluconazole resistant Candida auris clinical isolates have increased levels of cell wall chitin and increased susceptibility to a glucosamine-6-phosphate synthase inhibitor.

Authors:  Garima Shahi; Mohit Kumar; Andrzej S Skwarecki; Matt Edmondson; Atanu Banerjee; Jane Usher; Neil A R Gow; Sławomir Milewski; Rajendra Prasad
Journal:  Cell Surf       Date:  2022-02-25

8.  Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics - synthesis and properties.

Authors:  Joanna Stefaniak; Michał G Nowak; Marek Wojciechowski; Sławomir Milewski; Andrzej S Skwarecki
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

9.  Transport Deficiency Is the Molecular Basis of Candida albicans Resistance to Antifungal Oligopeptides.

Authors:  Marta Schielmann; Piotr Szweda; Katarzyna Gucwa; Marcin Kawczyński; Maria J Milewska; Dorota Martynow; Joachim Morschhäuser; Sławomir Milewski
Journal:  Front Microbiol       Date:  2017-11-07       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.